Figure 1: Combination of corrector and suppressor mutations restores ΔF508-CFTR folding, plasma membrane expression and function. Figure 2: VX-809 functions as a pharmacological chaperone of CFTR.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback